(Q33502847)

27 July 2017

1 reference

title

Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests (English)

1 reference

27 July 2017

R E Parchment

1

1 reference

27 July 2017

M Gordon

2

1 reference

27 July 2017

C K Grieshaber

3

1 reference

27 July 2017

C Sessa

4

1 reference

27 July 2017

D Volpe

5

1 reference

27 July 2017

M Ghielmini

6

1 reference

27 July 2017

publication date

1 April 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

9

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

357-364

1 reference

Human haemopoietic stem cell assays

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Pharmacologically guided phase I clinical trials based upon preclinical drug development

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Pharmacology and Clinical Toxicity of 4'-Iodo-4'-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrow

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

In vitro toxicity of 3′‐azido‐3′‐deoxythymidine, carbovir and 2′, 3′‐didehydro‐2′, 3′‐dideoxythymidine to human and murine haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Automated imaging and quantitation of tumor cells and CFU-GM colonies in microcapillary cultures: toward therapeutic index-based drug screening

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008245906772

7 January 2021

Identifiers

DOI

10.1023/A:1008245906772

1 reference

27 July 2017

1 reference